Novartis CEO says AI could cut drug development time to eight years

AI's integration in pharma could revolutionize drug development, enhancing efficiency and success rates, but regulatory and policy challenges remain. The post Novartis CEO says AI could cut drug development time to eight years appeared first on Crypto Briefing.
Read it in your languageMachine translation by Google of the publisher's page
More in AI
From the blog
Cathie Wood’s ARK Invest Acquires $90M in Anthropic Amid Ethereum Sales
Cathie Wood’s ARK Invest made a major move into artificial intelligence during Anthropic’s first day on the Nasdaq, purchasing nearly…
Hashi Launches Bitcoin-Backed Lending on Sui With Over 20 Partners
Bitcoin holders have a new way to access liquidity without selling their BTC. Hashi, a Bitcoin finance infrastructure protocol built…
MicroStrategy Chief Michael Saylor Details Bitcoin and STRC Purchase Logic
MicroStrategy Executive Chairman Michael Saylor explained the firm's capital allocation strategy, detailing how management decides between purchasing additional Bitcoin and…










